Antibody levels indicate need for two vaccine doses in those not infected before, single dose for those with past COVID-19, and booster shots for everybody
COVID-19 Antibody Responses after Vaccines and Infections
Mixed Vaccinations Generate Strong Immune Response
Combination of AstraZeneca vaccine as first dose and BioNTech/Pfizer vaccine as second dose could be beneficial, according to preprint
Synthesis of the Antiviral Nucleotide Analogue ddhCTP
Eight-step preparation starting from 4-N-benzoylcytidine
Teaming Up to Target Iron in Cancer Cells
Prochelators bind to serum albumin to form anti-cancer bioconjugates
New Opportunities for Use of mRNA Therapeutics
Evonik and Stanford University enter into research collaboration
Novavax's COVID-19 Vaccine Candidate
Shows 90 % overall efficacy and 100 % protection against moderate and severe disease in Phase 3 study, according to manufacturer
Most Accessed Articles: May 2021
Highlights from Chemistry Europe, ACES, and GDCh journals
Sustainable Antiviral Water Filter
Biodegradable membrane composed of protein nanofibrils and iron oxyhydroxide nanoparticles
SARS-CoV-2 Protease Can Target Human Proteins
Cleavage of host proteins by viral proteases could be related to COVID-19 symptoms
Lonza and Moderna Collaborate for Drug Substance Manufacturing
New mRNA production line in the Netherlands will support the manufacture of up to 300 million additional COVID-19 vaccine doses per year